VEA
ROIV icon

Virtus ETF Advisers’s Roivant Sciences ROIV Stock Holding History

Virtus ETF Advisers’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$637K Buy
18,007
+2,157
+14% +$63.7K 0.24% 107
2026
Q1 		$439K Buy
+15,850
New +$407K 0.2% 127
2025
Q1 		– Sell
-29,432
Closed -$348K – 724
2024
Q4 		$348K Sell
29,432
-1,035
-3% -$12.2K 0.14% 201
2024
Q3 		$352K Hold
30,467
– – 0.16% 216
2024
Q2 		$322K Sell
30,467
-3,766
-11% -$41.3K 0.16% 217
2024
Q1 		$361K Buy
34,233
+4,925
+17% +$53.1K 0.19% 207
2023
Q4 		$329K Sell
29,308
-2,030
-6% -$19.8K 0.21% 208
2023
Q3 		$366K Sell
31,338
-4,051
-11% -$45.8K 0.22% 185
2023
Q2 		$357K Sell
35,389
-7,271
-17% -$65K 0.21% 148
2023
Q1 		$315K Buy
42,660
+755
+2% +$6.22K 0.17% 194
2022
Q4 		$335K Sell
41,905
-21,151
-34% -$118K 0.17% 227
2022
Q3 		$203K Buy
63,056
+927
+1% +$3.59K 0.08% 318
2022
Q2 		$253K Buy
62,129
+43,583
+235% +$173K 0.09% 296
2022
Q1 		$92K Sell
18,546
-1,102
-6% -$7.27K 0.04% 316
2021
Q4 		$198K Buy
+19,648
New +$163K 0.07% 212

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Virtus ETF Advisers's ROIV Position: Q2 2026 in Review

Virtus ETF Advisers increased its Roivant Sciences (ROIV) stake by 14% in Q2 2026, buying an estimated $63.7K and bringing the position to 18,007 shares worth $637K. The position accounts for 0.24% of the portfolio, ranked #107.

Virtus ETF Advisers first reported a position in ROIV in Q4 2021 and has held it in 15 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Virtus ETF Advisers held 18,007 shares of Roivant Sciences worth $637K as of Q2 2026.
  • Virtus ETF Advisers bought 2,157 Roivant Sciences shares in Q2 2026, an estimated $63.7K.
  • Roivant Sciences made up 0.24% of Virtus ETF Advisers's portfolio in Q2 2026, its #107 holding.
  • Virtus ETF Advisers first reported a position in Roivant Sciences in Q4 2021 and has held it in 15 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.